Olaf Schmidt

797 total citations
37 papers, 505 citations indexed

About

Olaf Schmidt is a scholar working on Physiology, Pulmonary and Respiratory Medicine and Immunology. According to data from OpenAlex, Olaf Schmidt has authored 37 papers receiving a total of 505 indexed citations (citations by other indexed papers that have themselves been cited), including 32 papers in Physiology, 24 papers in Pulmonary and Respiratory Medicine and 4 papers in Immunology. Recurrent topics in Olaf Schmidt's work include Asthma and respiratory diseases (31 papers), Chronic Obstructive Pulmonary Disease (COPD) Research (12 papers) and Respiratory and Cough-Related Research (11 papers). Olaf Schmidt is often cited by papers focused on Asthma and respiratory diseases (31 papers), Chronic Obstructive Pulmonary Disease (COPD) Research (12 papers) and Respiratory and Cough-Related Research (11 papers). Olaf Schmidt collaborates with scholars based in Germany, United States and Austria. Olaf Schmidt's co-authors include Leif Bjermer, Lars Grönke, Dave Singh, Gary T. Ferguson, Petra Moroni-Zentgraf, R Abrahams, Christoph Hallmann, J Bolitschek, Nathan Bennett and Thomas B. Casale and has published in prestigious journals such as SHILAP Revista de lepidopterología, European Respiratory Journal and Thorax.

In The Last Decade

Olaf Schmidt

32 papers receiving 494 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Olaf Schmidt Germany 10 457 439 37 19 18 37 505
Theo A. Bantje Netherlands 8 391 0.9× 403 0.9× 31 0.8× 7 0.4× 14 0.8× 9 435
Arvind Manoharan United Kingdom 10 287 0.6× 270 0.6× 31 0.8× 8 0.4× 10 0.6× 17 333
Peter Arvidsson Sweden 10 408 0.9× 476 1.1× 87 2.4× 6 0.3× 6 0.3× 17 519
Wolfgang Seibold Germany 6 447 1.0× 478 1.1× 50 1.4× 15 0.8× 24 1.3× 15 528
Mark I. Allenby United Kingdom 6 210 0.5× 101 0.2× 10 0.3× 13 0.7× 10 0.6× 17 257
Nicoletta M. Azzolin Italy 8 512 1.1× 581 1.3× 94 2.5× 26 1.4× 12 0.7× 10 671
A Capristo Italy 8 153 0.3× 197 0.4× 81 2.2× 14 0.7× 13 0.7× 10 246
Sunny Jabbal United Kingdom 8 154 0.3× 143 0.3× 16 0.4× 25 1.3× 3 0.2× 18 205
Colleen Flynn Taylor United States 10 360 0.8× 333 0.8× 10 0.3× 11 0.6× 3 0.2× 11 393
Pekka Saarelainen Finland 5 302 0.7× 317 0.7× 32 0.9× 8 0.4× 5 0.3× 6 355

Countries citing papers authored by Olaf Schmidt

Since Specialization
Citations

This map shows the geographic impact of Olaf Schmidt's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Olaf Schmidt with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Olaf Schmidt more than expected).

Fields of papers citing papers by Olaf Schmidt

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Olaf Schmidt. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Olaf Schmidt. The network helps show where Olaf Schmidt may publish in the future.

Co-authorship network of co-authors of Olaf Schmidt

This figure shows the co-authorship network connecting the top 25 collaborators of Olaf Schmidt. A scholar is included among the top collaborators of Olaf Schmidt based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Olaf Schmidt. Olaf Schmidt is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Lommatzsch, Marek, Stephanie Korn, Olaf Schmidt, et al.. (2025). Real-world outcomes after 2 years of dupilumab therapy for severe asthma: the ProVENT study. PA477–PA477.
2.
Zaboli, Arian, Gianni Turcato, Serena Sibilio, et al.. (2025). The impact of COVID-19 pandemic on traumatic injuries in children: a longitudinal observational study. Emergency Care Journal.
3.
Renner, Andreas, Christoph Krall, Katrin Milger, et al.. (2025). Impact of Smoking on Biological Treatment Response in Patients From the German Severe Asthma (GAN) Registry. The Journal of Allergy and Clinical Immunology In Practice. 13(5). 1125–1138.e4. 1 indexed citations
4.
Kanniess, Frank, Marek Lommatzsch, Thomas Schultz, et al.. (2024). Validation of the German version of the Asthma Impairment and Risk Questionnaire (AIRQ). Pneumologie. 78(11). 912–921. 1 indexed citations
5.
Milger, Katrin, Dirk Koschel, Dirk Skowasch, et al.. (2024). Maintenance OCS Were Used More Frequently Than Biologics in Patients with Uncontrolled GINA 4/5 Asthma in Germany in 2019. Journal of Asthma and Allergy. Volume 17. 1093–1101. 4 indexed citations
6.
Papi, Alberto, et al.. (2023). Fixed-dose combination fluticasone/formoterol for asthma treatment in a real-world setting: meta-analysis of exacerbation rates and asthma control. European Clinical Respiratory Journal. 10(1). 2174642–2174642. 1 indexed citations
7.
Milger, Katrin, Hendrik Suhling, Dirk Skowasch, et al.. (2023). Response to Biologics and Clinical Remission in the Adult German Asthma Net Severe Asthma Registry Cohort. The Journal of Allergy and Clinical Immunology In Practice. 11(9). 2701–2712.e2. 37 indexed citations
8.
Pohl, Wolfgang, Katrin Milger, Dirk Skowasch, et al.. (2023). Characterization of Obesity in Severe Asthma in the German Asthma Net. The Journal of Allergy and Clinical Immunology In Practice. 11(11). 3417–3424.e3. 12 indexed citations
9.
Timmermann, Hartmut, Katrin Milger, J. Christian Virchow, et al.. (2023). Health Care Situation in the Treatment of Uncontrolled GINA Step 4/5 Patients in Germany. Journal of Asthma and Allergy. Volume 16. 813–820. 1 indexed citations
10.
Suhling, Hendrik, Dirk Skowasch, Karl‐Christian Bergmann, et al.. (2023). Initiation, response assessment, and switch of antibody therapies in patients with severe asthma – A survey among German specialists. World Allergy Organization Journal. 16(12). 100844–100844. 2 indexed citations
11.
Korn, Stephanie, Olaf Schmidt, Hartmut Timmermann, et al.. (2023). Real-World Characteristics of Patients with Severe Asthma prior to Starting Dupilumab: The ProVENT Study. Respiration. 103(1). 10–21.
12.
Buhl, Roland, et al.. (2022). Real-World Treatment of Patients Newly Diagnosed with Chronic Obstructive Pulmonary Disease: A Retrospective German Claims Data Analysis. International Journal of COPD. Volume 17. 2355–2367. 7 indexed citations
13.
14.
Vogelberg, Christian, Michael E. Engel, Jonathan A. Bernstein, et al.. (2018). Tiotropium add-on therapy improves lung function in children with symptomatic moderate asthma. The Journal of Allergy and Clinical Immunology In Practice. 6(6). 2160–2162.e9. 32 indexed citations
15.
Aalbers, René, M. Reza Maleki-Yazdi, Alan Hamilton, et al.. (2015). Randomized, Double-Blind, Dose-Finding Study for Tiotropium when Added to Olodaterol, Administered via the Respimat® Inhaler in Patients with Chronic Obstructive Pulmonary Disease. Advances in Therapy. 32(9). 809–822. 15 indexed citations
16.
Singh, Dave, Gary T. Ferguson, J Bolitschek, et al.. (2015). Tiotropium + olodaterol shows clinically meaningful improvements in quality of life. Respiratory Medicine. 109(10). 1312–1319. 126 indexed citations
17.
Schmidt, Olaf, et al.. (2014). IMPLEMENTATION OF BIOFEEDBACK IN A CLOSED LOOP OF HEART RATE VARIABILITY AND PACED BREATHING IN PATIENTS WITH ARTERIAL HYPERTENSION. SHILAP Revista de lepidopterología. 3 indexed citations
18.
Kerstjens, Huib A.M., Eugene R. Bleecker, Eli O. Meltzer, et al.. (2013). Tiotropium as add-on therapy to inhaled corticosteroids for patients with symptomatic asthma: Lung function and safety. European Respiratory Journal. 42(Suppl 57). 4629–4629. 4 indexed citations
19.
Kerstjens, Huib A.M., Eugene R. Bleecker, Eli O. Meltzer, et al.. (2013). Tiotropium as add-on to inhaled corticosteroids significantly improves asthma control as reflected by the ACQ responder rate. European Respiratory Journal. 42(Suppl 57). P4130–P4130. 5 indexed citations
20.
Schmidt, Olaf & Werner Lang. (2008). Heparin-induzierte Thrombozytopenie Typ II: Intra- und postoperative Lepirudin-Therapie bei akuter Extremitätenischämie. DMW - Deutsche Medizinische Wochenschrift. 123(41). 1207–1210.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Theo A. Bantje Breakdown of academic impact, for papers by Arvind Manoharan Breakdown of academic impact, for papers by Peter Arvidsson Breakdown of academic impact, for papers by Wolfgang Seibold Breakdown of academic impact, for papers by Mark I. Allenby Breakdown of academic impact, for papers by Nicoletta M. Azzolin Breakdown of academic impact, for papers by A Capristo Breakdown of academic impact, for papers by Sunny Jabbal Breakdown of academic impact, for papers by Colleen Flynn Taylor Breakdown of academic impact, for papers by Pekka Saarelainen
Rankless by CCL
2026